Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-12-19
2009-10-20
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S399000
Reexamination Certificate
active
07605129
ABSTRACT:
This invention relates to a protein, termed INSP105, herein identified as a splice variant of human placental growth hormone and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
REFERENCES:
patent: 5597709 (1997-01-01), Rosen et al.
Cooke et al. (J. Biol. Chem. 263 (18): 9001-9006, 1988).
Boguszewski, C. et al. “Cloning of two novel growth hormone transcripts expressed in human placenta”J. Clin Endocrinol Metab, 1998, 83:2878-2885.
De Tiani Mariastella
Fagan Richard Joseph
Phelps Christopher Benjamin
Power Christine
Rodrigues Tania Maria
Saliwanchik Lloyd & Saliwanchik
Saoud Christine J
LandOfFree
Splice variant of human placental growth hormone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Splice variant of human placental growth hormone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Splice variant of human placental growth hormone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112857